P3 Health Partners Inc. Class A Common Stock (PIII) Stock
Key stats
- Market cap
- $10.21M
- Price / Earnings ratio
- -0.3x
- EPS (TTM)
- -$23.21
- Volume
- Loading
- 52-week high
- $16.89
- 52-week low
- $1.52
Source: third-party data provider, as of November 13, 2026
Compare with PIII
Recent news

P3 Health Partners Schedules Third Quarter 2026 Earnings Release and Conference Call
P3 Health Partners Schedules Third Quarter 2026 Earnings Release and Conference Call
PIII

P3 Health Partners Inc. Announces Appointment of Chief Clinical Officer
P3 Health Partners Inc. Announces Appointment of Chief Clinical Officer
PIII

P3 Health Partners Q2 Earnings Call Highlights
P3 Health Partners Q2 Earnings Call Highlights
PIII

P3 Health Partners Announces Second Quarter 2026 Results
P3 Health Partners Announces Second Quarter 2026 Results
PIII
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 26.32
- MACD 12/26/9
- -0.64
- EMA 9 of MACD
- -0.68
- MACD histogram
- 0.04
- SMA 50
- $5.79
- Price below SMA 50
- EMA 50
- $5.56
- Price below EMA 50
- SMA 200
- $6.58
- Price below SMA 200
- EMA 200
- $5.97
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

P3 Health Partners Schedules Third Quarter 2026 Earnings Release and Conference Call
P3 Health Partners Schedules Third Quarter 2026 Earnings Release and Conference Call
PIII

P3 Health Partners Inc. Announces Appointment of Chief Clinical Officer
P3 Health Partners Inc. Announces Appointment of Chief Clinical Officer
PIII

P3 Health Partners Q2 Earnings Call Highlights
P3 Health Partners Q2 Earnings Call Highlights
PIII

P3 Health Partners Announces Second Quarter 2026 Results
P3 Health Partners Announces Second Quarter 2026 Results
PIII

P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call
P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call
PIII

Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners
Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners
PIII

P3 Health Partners Announces First Quarter 2026 Results
P3 Health Partners Announces First Quarter 2026 Results
PIII
News tone: automated (AI) classification of the article's content, not a price prediction.
About P3 Health Partners Inc. Class A Common Stock
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Aric Coffman M.D. | CEO, President & Director | 1974 |
| Mr. Leif Pedersen | Chief Financial Officer | 1976 |
| Mr. William Bettermann | Executive VP & COO | — |
| Dr. Amir Bacchus M.B.A., M.D. | Co-Founder, Chief Medical Officer & Director | 1965 |
| Mr. Devery Goodey | Senior Vice President of Technology | — |
| Ms. Sarah Bussmann B.S.N., CRNI, M.H.A., R.N. | Chief Administrative Officer | — |
| Mr. William Hoover | Investor Relations Officer | — |
| Mr. Todd M. Smith | Chief Legal Officer, Chief Compliance Officer & Corporate Secretary | — |
| Ms. Kassi Belz APR | Executive Vice President of Marketing & Communications | — |
| Ms. Shelly Martin | Regional President of Nevada & Arizona | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 26.32
- MACD 12/26/9
- -0.64
- EMA 9 of MACD
- -0.68
- MACD histogram
- 0.04
- SMA 50
- $5.79
- Price below SMA 50
- EMA 50
- $5.56
- Price below EMA 50
- SMA 200
- $6.58
- Price below SMA 200
- EMA 200
- $5.97
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $4.00
- Average
- $4.00
- High
- $4.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +32.8 | -16.3 | -11.2 | -9.6 | -23.8 | -35.7 | -34.8 |



